Linnea SA

Vinpocetine is a semi-synthetic derivative, extracted using a proprietary method to Linnea, vetted to GMP-standard quality controls, resulting in a high-quality profile and outstanding therapeutic value end product. Linnea’s Vinpocetine is compliant with the European Pharmacopoeia and is CEP certified. Linne has been producing Vinpocetine since 1982, made available in two product varities, namely pharmaceutical and dietary ingredients If you want to learn more: --> https://lnkd.in/d3sR9kv2 --> Contact us on sales@linnea.ch #Linnea #pharma #API #Vinpocetine #GMP #DMF #GACP

5-hydroxytryptophan is an amino-acid with nootropic and antidepressant actions, naturally present in the brain and found in food in small doses. Exogenous therapeutic 5 HTP is isolated from the seeds of the African plant Griffonia simplicifolia. Linnea's 5 HTP is manufactured in Linnea's GMP facility in Switzerland, it is DMF certified and GACP Compliant. If you want to learn more: --> https://lnkd.in/dBh9kc46 --> Contact us on sales@linnea.ch #Linnea #pharma #API #5HTP #GMP #DMF #GACP

Linnea's Ginkgo Biloba dry extract is derived using two different methods, allowing to obtain two different products: Ginkgo Biloba EPG 246, and Ginkgo Biloba Ethanol, suitable for pharmaceutical and food applications respectively. This product is compliant with Ph. Eur., DMF certified and GACP compliant. Linnea has been producing Ginkgo Biloba since 1982, in its GMP facility in Ticino, Switzerland. If you want to learn more: --> https://lnkd.in/eHumsYmP --> Contact us on sales@linnea.ch #Linnea #pharma #API #ginkgobiloba #GMP #DMF #GACP

Linnea has been producing Butylscopolamine since 1985, in its GMP facilities in Switzerland. Butylscopolamine is a peripherally-acting antimuscarinic and anticholinergic agent, that is obtained from the leaves of the Duboisia plant. Linnea's Butylscopolamine is available for oral grade pharmaceutical forms as well as for injectables, with Hyject™. Discover Linnea Butylscopolamine --> https://lnkd.in/dHphAKwD Reach out to us on sales@linnea.ch #Linnea #pharma #API #butylscopolamine #duboisia #GMP

Next week, July 30th, is the International Day of Friendship, proclaimed by the UN General Assembly back in 2011. It represents an effort to increase mutual understanding, understanding of other cultures, countries, peoples, to inspire bridges between communities. It's a day dedicated to sharing the human spirit, through acts of friendship. We hope that you will mark it by being a friend, having a friend, celebrating a friend. Learn more about Linnea --> https://lnkd.in/dTbNRBhT #Linnea #togetherness #dayoffriendship #respect United Nations

Did you know? Linnea's vincamine Active Pharmaceutical Ingredient is derived from Voacanga africana, a plant that as the name suggest, is native to tropical Africa. This small plant's root bark and its seeds contain a high number of alkaloids, and many benefits. Linnea's Vincamine is extracted and manufactured using a proprietary method in its GMP facilites in Switzerland, it's vetted according to GMP-standard contorls, resulting in a state-of-the-art product. The part of the plant used are the seeds, the appearance of the end product is one of a white microcrystaline powder, and it's suitable both for pharmaceutical and dietary uses. Discover Linnea Vincamine --> https://lnkd.in/d3sR9kv2 Reach out to us on sales@linnea.ch #Linnea #pharma #API #voacanga #vincamine #GMP #GACP

In 2023, Linnea's Chief Commercial Officer, Giorgio Ferdinandi, wrote a piece on the top three considerations manufacturers of Cannabis-derived API's must make, not only to ensure effective procurement, but most importantly, to ensure quality of the raw materials. The article touches on the importance of GACP and GMP, very difficult to obtain but extremely important to the quality of pharmaceutical and medical grade API's. Read the article now --> https://ow.ly/9x3U50SnjaU If you want to know more about Linnea's approach, visit out website --> https://ow.ly/xnSn50SnjaS Reach out to us on sales@linnea.ch #Linnea #LinneaCannabinoids #cannabinoids #leadership #API #CBD #CBG #GMP #GACP Giorgio Ferdinandi Supply & Demand Chain Executive

Linnea's Vincamine is now CEP certified! ✅ The European Directorate for the Quality of Medicines & Healthcare (EDQM) has issued a CEP certificate for Linnea’s Vincamine product, making Linnea the first company in the world to have a CEP-certified Vincamine extract. To learn more about Linnea's Vincamine and the CEP certification, visit https://lnkd.in/dwcv-SEd To schedule an informative meeting contact sales@linnea.ch #CEP #EDQM #vincamine #API #botanical #extract #GMP #GACP

We are proud to announce that the Swiss authorities have granted Linnea a GID (Guarantee of Identity) certificate for its products. This document certifies that the identity of the raw materials (APIs) supplied by Linnea SA to Swiss pharmacies meet the requirements listed in the "Rules of Good Manufacturing Practice for medical products in small quantities". Linnea can now sell small batches of API's to Swiss pharmacies, and they are able to incorporate them into the end-products, without performing the identity test. To learn more about Linnea's portfolio visit --> www.linnea.ch #Linnea #GID #GACP #API #conformity #botanicalextracts #SwissPharmacies

What a great event Cannabis Europa 2024 was! Thoroughly enjoyed the atmosphere at the Barbican, networking and sharing information about Linnea's standardized, GMP, Active Pharmaceutical Ingredients, in interviews and directly with visitors. #CE2024 #cannabinoids #CBD #CBG #LinneaSA